{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:48:33Z","timestamp":1791287313422,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University Medical Center of the Johannes Gutenberg University of Mainz, Germany","award":["Intramural Research Funding"],"award-info":[{"award-number":["Intramural Research Funding"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with multiple myeloma report more problems with quality of life (QoL) than other haematological malignancies over the course of their incurable illness. The patient-centred Myeloma Patient Outcome Scale (MyPOS) was developed to assess and monitor symptoms and supportive care factors in routine care. Our aim was to translate and culturally adapt the outcome measure to the German context, and to explore its face and content validity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Translation and cultural adaptation following established guidelines used an exploratory, sequential mixed method study design. Steps included: (1) forward translation to German; (2) backward translation to English; (3) expert review; (4) focus groups with the target population (patients, family members, healthcare professionals) to achieve conceptual equivalence; (5) cognitive interviews using Tourangeau\u2019s model with think-aloud technique to evaluate comprehension and acceptability; (6) final review. Results were analysed using thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cultural and linguistic differences were noted between the German and English original version. The focus groups (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911) and cognitive interviews (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099) both highlighted the need for adapting individual items and their answer options to the German healthcare context. Greater individuality regarding need for information with the right to not be informed was elaborated by patients. While the comprehensive nature of the tool was appreciated, item wording regarding satisfaction with healthcare was deemed not appropriate in the German context. Before implementation into routine care, patients\u2019 concerns about keeping their MyPOS data confidential need to be addressed as a barrier, whereas the MyPOS itself was perceived as a facilitator\/prompt for a patient-centred discussion of QoL issues.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>With adaptations to answer options and certain items, the German version of the MyPOS can help monitor symptoms and problems afflicting myeloma patients over the course of the disease trajectory. It can help promote a model of comprehensive supportive and patient-centred care for these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-06730-7","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:05:06Z","timestamp":1584965106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care"],"prefix":"10.1186","volume":"20","author":[{"given":"Christina","family":"Gerlach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Ferner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Munder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ramsenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"6730_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"6730_CR2","unstructured":"B\u00f6ckmann L, Jedinger S, Kirschey T. Vierte regionalisierte Bev\u00f6lkerungs-vorausberechnung [4th regionalised population forecast]: Office of Statistics Rhineland-Palatine; 2015. https:\/\/www.statistik.rlp.de\/dokumente\/stat_analysen\/rp2060_bj2013. Accessed 17 Oct 2019."},{"key":"6730_CR3","unstructured":"Robert-Koch-Institut. Krebs in Deutschland 2011\/2012 [Cancer in Germany 2011\/2012]: Robert-Koch-Institut; 2015. https:\/\/www.krebsdaten.de\/Content\/Krebs_in_Deutschland\/kid_2015. Accessed 17 Oct 2019."},{"key":"6730_CR4","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.ejca.2006.01.065","volume":"42","author":"B Sirohi","year":"2006","unstructured":"Sirohi B, Powles R. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. Eur J Cancer. 2006;42:1671\u201383.","journal-title":"Eur J Cancer"},{"key":"6730_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ajh.23390","volume":"88","author":"SV Rajkumar","year":"2013","unstructured":"Rajkumar SV. Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol. 2013;88:226\u201335.","journal-title":"Am J Hematol"},{"key":"6730_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1200\/JCO.18.02096","volume":"37","author":"J Mikhael","year":"2019","unstructured":"Mikhael J, Ismaila N, Cheung MC, Costello C, Dhodapkar MV, Kumar S, Lacy M, Lipe B, Little RF, Nikonova A, Omel J, Peswani N, Prica A, Raje N, Seth R, Vesole DH, Walker I, Whitley A, Wildes TM, Wong SW, Martin T. Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline. J Clin Oncol. 2019;37:1228\u201363.","journal-title":"J Clin Oncol"},{"key":"6730_CR7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson KC. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"6730_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2141.2004.05207.x","volume":"127","author":"KJ Phekoo","year":"2004","unstructured":"Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillett D, M\u00f8ller H, Consultant Haematologists, South Thames Haematology Specialist Committee. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol. 2004;127:299\u2013304.","journal-title":"Br J Haematol"},{"key":"6730_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","volume":"83","author":"AT Johnsen","year":"2009","unstructured":"Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M. Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol. 2009;83:139\u201348.","journal-title":"Eur J Haematol"},{"key":"6730_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/leu.2013.185","volume":"27","author":"P Sonneveld","year":"2013","unstructured":"Sonneveld P, Verelst SG, Lewis P, Gray-Schopfer V, Hutchings A, Nixon A, Petrucci MT. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia. 2013;27:1959\u201369.","journal-title":"Leukemia."},{"key":"6730_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pon.1710","volume":"20","author":"A Molassiotis","year":"2011","unstructured":"Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology. 2011;20:88\u201397.","journal-title":"Psychooncology."},{"key":"6730_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00520-009-0793-1","volume":"19","author":"A Molassiotis","year":"2011","unstructured":"Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Living with multiple myeloma: experiences of patients and their informal caregivers. Support Care Cancer. 2011;19:101\u201311.","journal-title":"Support Care Cancer"},{"key":"6730_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-2354.2010.01234.x","volume":"20","author":"K Maher","year":"2011","unstructured":"Maher K, de Vries K. An exploration of the lived experiences of individuals with relapsed multiple myeloma. Eur J Cancer Care (Engl). 2011;20:267\u201375.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"6730_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/ejh.12790","volume":"97","author":"C Ramsenthaler","year":"2016","unstructured":"Ramsenthaler C, Kane P, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ. Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. Eur J Haematol. 2016;97:416\u201329.","journal-title":"Eur J Haematol"},{"key":"6730_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom monitoring with patient-reported outcomes during routine Cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557\u201365.","journal-title":"J Clin Oncol"},{"key":"6730_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jpainsymman.2014.07.010","volume":"49","author":"SN Etkind","year":"2015","unstructured":"Etkind SN, Daveson BA, Kwok W, Witt J, Bausewein C, Higginson IJ, Murtagh FE. Capture, transfer, and feedback of patient-centered outcomes data in palliative care populations: does it make a difference? A systematic review. J Pain Symptom Manag. 2015;49:611\u201324.","journal-title":"J Pain Symptom Manag"},{"key":"6730_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ejh.12012","volume":"89","author":"TR Osborne","year":"2012","unstructured":"Osborne TR, Ramsenthaler C, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ. What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. Eur J Haematol. 2012;89:437\u201357.","journal-title":"Eur J Haematol"},{"key":"6730_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jpainsymman.2011.06.019","volume":"43","author":"LI Wagner","year":"2012","unstructured":"Wagner LI, Robinson D, Weiss M, Katz M, Greipp PR, Fonseca R, Cella D. Content development for the functional assessment of Cancer therapy-multiple myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction. J Pain Symptom Manag. 2012;43:1094\u2013104.","journal-title":"J Pain Symptom Manag"},{"key":"6730_CR19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.ejca.2007.04.022","volume":"43","author":"K Cocks","year":"2007","unstructured":"Cocks K, Cohen D, Wisl\u00f8ff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J. EORTC Quality of Life Group. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007;43:1670\u20138.","journal-title":"Eur J Cancer"},{"key":"6730_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1756-8722-6-13","volume":"6","author":"D Jones","year":"2013","unstructured":"Jones D, Vichaya EG, Wang XS, Williams LA, Shah ND, Thomas SK, Johnson VE, Champlin RE, Cleeland CS, Mendoza TR. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol. 2013;6:13.","journal-title":"J Hematol Oncol"},{"key":"6730_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7525-12-35","volume":"12","author":"I Proskorovsky","year":"2014","unstructured":"Proskorovsky I, Lewis P, Williams CD, Jordan K, Kyriakou C, Ishak J, Davies FE. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Health Qual Life Outcomes. 2014;12:35.","journal-title":"Health Qual Life Outcomes"},{"key":"6730_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12885-015-1261-6","volume":"15","author":"TR Osborne","year":"2015","unstructured":"Osborne TR, Ramsenthaler C, Schey SA, Siegert RJ, Edmonds PM, Higginson IJ. Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the myeloma patient outcome scale (MyPOS). BMC Cancer. 2015;15:280.","journal-title":"BMC Cancer"},{"key":"6730_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/qshc.8.4.219","volume":"8","author":"J Hearn","year":"1998","unstructured":"Hearn J, Higginson IJ. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative care Core audit project advisory group. Qual Health Care. 1998;8:219\u201327.","journal-title":"Qual Health Care"},{"key":"6730_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0269216319854264","volume":"33","author":"FE Murtagh","year":"2019","unstructured":"Murtagh FE, Ramsenthaler C, Firth A, Groeneveld EI, Lovell N, Simon ST, Denzel J, Guo P, Bernhardt F, Schildmann E, van Oorschot B, Hodiamont F, Streitwieser S, Higginson IJ, Bausewein C. A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the integrated palliative care outcome scale (IPOS). Palliat Med. 2019;33:1045\u201357.","journal-title":"Palliat Med"},{"key":"6730_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0269216315608348","volume":"30","author":"EK Schildmann","year":"2016","unstructured":"Schildmann EK, Groeneveld EI, Denzel J, Brown A, Bernhardt F, Bailey K, Guo P, Ramsenthaler C, Lovell N, Higginson IJ, Bausewein C, Murtagh FE. Discovering the hidden benefits of cognitive interviewing in two languages: the first phase of a validation study of the integrated palliative care outcome scale. Palliat Med. 2016;30:599\u2013610.","journal-title":"Palliat Med"},{"key":"6730_CR26","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s11136-017-1660-z","volume":"26","author":"C Ramsenthaler","year":"2017","unstructured":"Ramsenthaler C, Gao W, Siegert RJ, Schey SA, Edmonds PM, Higginson IJ. Longitudinal validity and reliability of the myeloma patient outcome scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods. Qual Life Res. 2017;26:2931\u201347.","journal-title":"Qual Life Res"},{"key":"6730_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ejh.12864","volume":"98","author":"JM Davies","year":"2017","unstructured":"Davies JM, Osborne TR, Edmonds PM, Schey SA, Devereux S, Higginson IJ, Ramsenthaler C. The myeloma patient outcome scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma. Eur J Haematol. 2017;98:508\u201316.","journal-title":"Eur J Haematol"},{"key":"6730_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S1047-2797(97)00030-6","volume":"7","author":"RB Warnecke","year":"1997","unstructured":"Warnecke RB, Johnson TP, Chavez N, Sudman S, O'Rourke DP, Lacey L, Horm J. Improving question wording in surveys of culturally diverse populations. Ann Epidemiol. 1997;7:334\u201342.","journal-title":"Ann Epidemiol"},{"key":"6730_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/nur.20364","volume":"33","author":"S Sidani","year":"2010","unstructured":"Sidani S, Guruge S, Miranda J, Ford-Gilboe M, Varcoe C. Cultural adaptation and translation of measures: an integrated method. Res Nurs Health. 2010;33:133\u201343.","journal-title":"Res Nurs Health"},{"key":"6730_CR30","doi-asserted-by":"publisher","DOI":"10.4135\/9781412983655","volume-title":"Cognitive interviewing: a tool for improving questionnaire design","author":"GB Willis","year":"2005","unstructured":"Willis GB. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks: Sage Publications; 2005."},{"key":"6730_CR31","volume-title":"Designing and conducting mixed methods research","author":"JW Creswell","year":"2017","unstructured":"Creswell JW, Clark Vicki LP. Designing and conducting mixed methods research. Newbury Park: Sage; 2017."},{"key":"6730_CR32","unstructured":"Antunes B, Daveson B, Ramsenthaler C, Benalia H, Lopes Ferreira P, Higginson I. The palliative care outcome scale manual for cross-cultural adaptation and psychometric validation: Cicely Saunders Institute, King\u2019s College London; 2012. http:\/\/pos-pal.org\/Resources.php. Accessed 17 Oct 2019."},{"key":"6730_CR33","unstructured":"Kulis D, Bottomley A, Velikova G, Greimel E, Koller M. EORTC Quality of Life Group translation procedure manual. European Organization for Research and Treatment of Cancer. 2017. http:\/\/www.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/translation_ manual_2017.pdf. Accessed 17 Oct 2019."},{"key":"6730_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P, Translation ITFf, Cultural A. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8:94\u2013104.","journal-title":"Value Health"},{"key":"6730_CR35","unstructured":"Chavez L, Canino G. Toolkit on translating and adapting instruments. Cambridge: Human Services Research Institute; 2005."},{"key":"6730_CR36","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s11136-009-9540-9","volume":"18","author":"M Brod","year":"2009","unstructured":"Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263\u201378.","journal-title":"Qual Life Res"},{"key":"6730_CR37","volume-title":"Qualitative methods for Health Research","author":"J Green","year":"2009","unstructured":"Green J, Thorogood N. Qualitative methods for Health Research. 2nd ed. London: Sage Publications; 2009.","edition":"2"},{"key":"6730_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/1471-2407-14-496","volume":"14","author":"TR Osborne","year":"2014","unstructured":"Osborne TR, Ramsenthaler C, de Wolf-Linder S, Schey SA, Siegert RJ, Edmonds PM, Higginson IJ. Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life. BMC Cancer. 2014;14:496.","journal-title":"BMC Cancer"},{"key":"6730_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/pon.1295","volume":"12","author":"G Velikova","year":"2008","unstructured":"Velikova G, Awad N, Coles-Gale R, Wright EP, Brown JM, Selby PJ. The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views. Psychooncology. 2008;12:690\u20138.","journal-title":"Psychooncology"},{"key":"6730_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpainsymman.2005.01.017","volume":"30","author":"C Bausewein","year":"2005","unstructured":"Bausewein C, Fegg M, Radbruch L, Nauck F, von Mackensen S, Borasio GD, Higginson IJ. Validation and clinical application of the German version of the palliative care outcome scale. J Pain Symptom Manag. 2005;30:51\u201362.","journal-title":"J Pain Symptom Manag"},{"key":"6730_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1586\/erp.11.102","volume":"12","author":"M Koller","year":"2012","unstructured":"Koller M, Kantzer V, Mear I, Zarzar K, Martin M, Greimel E, Bottomley A, Arnott M, Kuli\u015b D, ISOQOL TCA-SIG. The process of reconciliation: evaluation of guidelines for translating quality-of-life questionnaires. Expert Rev Pharmacoecon Outcomes Res. 2012;12:189\u201397.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"6730_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/acp.2350050307","volume":"5","author":"GB Willis","year":"1991","unstructured":"Willis GB, Royston P, Bercini D. The use of verbal report methods in the development and testing of survey questionnaires. Appl Cogn Psychol. 1991;5:251\u201367.","journal-title":"Appl Cogn Psychol"},{"key":"6730_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1073191112436671","volume":"21","author":"J Lee","year":"2014","unstructured":"Lee J. Conducting cognitive interviews in cross-National Settings. Assessment. 2014;21:227\u201340.","journal-title":"Assessment."},{"key":"6730_CR44","first-page":"73","volume-title":"Cognitive aspects of survey methodology: building a bridge between disciplines","author":"R Tourangeau","year":"1984","unstructured":"Tourangeau R. Cognitive sciences and survey methods. In: Jabine TB, editor. Cognitive aspects of survey methodology: building a bridge between disciplines. Washington, DC: National Academy Press; 1984. p. 73\u2013101."},{"key":"6730_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-684X-4-7","volume":"4","author":"AP Abernethy","year":"2005","unstructured":"Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC. The Australia-modified Karnofsky performance status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care. 2005;4:7.","journal-title":"BMC Palliat Care."},{"key":"6730_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"6730_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/erp.10.30","volume":"10","author":"C Kerr","year":"2010","unstructured":"Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10:269\u201381.","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"key":"6730_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12904-017-0232-x","volume":"16","author":"I Beck","year":"2017","unstructured":"Beck I, Olsson M\u00f6ller U, Malmstr\u00f6m M, Klarare A, Samuelsson H, Lundh Hagelin C, Rasmussen B, F\u00fcrst CJ. Translation and cultural adaptation of the integrated palliative care outcome scale including cognitive interviewing with patients and staff. BMC Palliat Care. 2017;16:49.","journal-title":"BMC Palliat Care"},{"key":"6730_CR49","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/1471-2296-14-198","volume":"14","author":"E Blozik","year":"2013","unstructured":"Blozik E, Scherer M, Lacruz ME, Ladwig KH. KORA study group. Diagnostic utility of a one-item question to screen for depressive disorders: results from the KORA F3 study. BMC Fam Pract. 2013;14:198.","journal-title":"BMC Fam Pract"},{"key":"6730_CR50","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/0269215507074056","volume":"21","author":"L Vahter","year":"2007","unstructured":"Vahter L, Kreegipuu M, Talvik T, Gross-Paju K. One question as a screening instrument for depression in people with multiple sclerosis. Clin Rehabil. 2007;21:460\u20134.","journal-title":"Clin Rehabil"},{"key":"6730_CR51","doi-asserted-by":"publisher","first-page":"e0208536","DOI":"10.1371\/journal.pone.0208536","volume":"14","author":"S Veronese","year":"2019","unstructured":"Veronese S, Rabitti E, Costantini M, Valle A, Higginson I. Translation and cognitive testing of the Italian integrated palliative outcome scale (IPOS) among patients and healthcare professionals. PLoS One. 2019;14:e0208536.","journal-title":"PLoS One"},{"key":"6730_CR52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12904-019-0422-9","volume":"18","author":"AC Sterie","year":"2019","unstructured":"Sterie AC, Bernard M. Challenges in a six-phase process of questionnaire adaptation: findings from the French translation of the integrated palliative care outcome scale. BMC Palliat Care. 2019;18:38.","journal-title":"BMC Palliat Care."},{"key":"6730_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2141.1999.01206.x","volume":"104","author":"ML Stead","year":"1999","unstructured":"Stead ML, Brown JM, Velikova G, Kaasa S, Wisl\u00f8ff F, Child JA, Hippe E, Hjorth M, Sezer O, Selby P. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer study group on quality of life. Br J Haematol. 1999;104:605\u201311.","journal-title":"Br J Haematol"},{"key":"6730_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00008526-200601001-00005","volume":"18","author":"AW Heinemann","year":"2006","unstructured":"Heinemann AW, Fisher WP, Gershon R. Improving health care quality with outcomes management. J Prosthet Orthot. 2006;18:46\u201350.","journal-title":"J Prosthet Orthot"},{"key":"6730_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/00005650-200009002-00029","volume":"38","author":"SH Kaplan","year":"2000","unstructured":"Kaplan SH, Kravitz RL, Greenfield S. A critique of current uses of health status for the assessment of treatment effectiveness and quality of care. Med Care. 2000;38:184\u201391.","journal-title":"Med Care"},{"key":"6730_CR56","first-page":"153","volume":"15","author":"B Ferrell","year":"1992","unstructured":"Ferrell B, Grant M, Schmidt GM, Rhiner M, Whitehead C, Fonbuena P, Forman SJ. The meaning of quality of life for bone marrow transplant survivors. Part 1. The impact of bone marrow transplant on quality of life. Cancer Nurs. 1992;15:153\u201360.","journal-title":"Cancer Nurs"},{"key":"6730_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1017\/S1478951506060470","volume":"4","author":"JF Dahan","year":"2006","unstructured":"Dahan JF, Auerbach CF. A qualitative study of the trauma and posttraumatic growth of multiple myeloma patients treated with peripheral blood stem cell transplant. Palliat Support Care. 2006;4:365\u201387.","journal-title":"Palliat Support Care"},{"issue":"1","key":"6730_CR58","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12885-019-5467-x","volume":"19","author":"JA Parsons","year":"2019","unstructured":"Parsons JA, Greenspan NR, Baker NA, McKillop C, Hicks LK, Chan O. Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study. BMC Cancer. 2019;19(1):264.","journal-title":"BMC Cancer"},{"key":"6730_CR59","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1200\/JCO.2013.51.4315","volume":"31","author":"LE Carlson","year":"2013","unstructured":"Carlson LE. Screening alone is not enough: the importance of appropriate triage, referral, and evidence-based treatment of distress and common problems. J Clin Oncol. 2013;31:3616\u20137.","journal-title":"J Clin Oncol"},{"key":"6730_CR60","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1200\/JCO.2012.48.3040","volume":"31","author":"W Hollingworth","year":"2013","unstructured":"Hollingworth W, Metcalfe C, Mancero S, Harris S, Campbell R, Biddle L, McKell-Redwood D, Brennan J. Are needs assessments cost effective in reducing distress among patients with cancer? A randomized controlled trial using the distress thermometer and problem list. J Clin Oncol. 2013;31:3631\u20138.","journal-title":"J Clin Oncol"},{"key":"6730_CR61","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1200\/JCO.2014.58.7824","volume":"33","author":"JN Dionne-Odom","year":"2015","unstructured":"Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, Frost J, Dragnev KH, Akyar I, Hegel MT, Bakitas MA. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced Cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33:1446\u201352.","journal-title":"J Clin Oncol"},{"key":"6730_CR62","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/0269216318824525","volume":"33","author":"D McCaughan","year":"2019","unstructured":"McCaughan D, Roman E, Smith AG, Garry AC, Johnson MJ, Patmore RD, Howard MR, Howell DA. Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: a qualitative study. Palliat Med. 2019;33:518\u201330.","journal-title":"Palliat Med"},{"key":"6730_CR63","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/SPC.0000000000000385","volume":"12","author":"TW LeBlanc","year":"2018","unstructured":"LeBlanc TW, El-Jawahri A. Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care? Curr Opin Support Palliat Care. 2018;12:530\u201353.","journal-title":"Curr Opin Support Palliat Care"},{"key":"6730_CR64","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jpainsymman.2017.04.012","volume":"54","author":"J Porta-Sales","year":"2017","unstructured":"Porta-Sales J, Guerrero-Torrelles M, Moreno-Alonso D, Sarr\u00e0-Escarr\u00e9 J, Clap\u00e9s-Puig V, Trelis-Navarro J, Sureda-Balar\u00ed A. Fern\u00e1ndez De Sevilla-Ribosa a. is early palliative care feasible in patients with multiple myeloma? J Pain Symptom Manag. 2017;54:692\u2013700.","journal-title":"J Pain Symptom Manag"},{"key":"6730_CR65","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1200\/JCO.2017.73.2800","volume":"35","author":"A El-Jawahri","year":"2017","unstructured":"El-Jawahri A, Traeger L, Greer JA, VanDusen H, Fishman SR, LeBlanc TW, Pirl WF, Jackson VA, Telles J, Rhodes A, Li Z, Spitzer TR, McAfee S, Chen YA, Temel JS. Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol. 2017;35:3714\u201321.","journal-title":"J Clin Oncol"},{"key":"6730_CR66","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1001\/jama.2016.16786","volume":"316","author":"A El-Jawahri","year":"2016","unstructured":"El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S, Chen YA, Lee SS, Temel JS. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2016;316:2094\u2013103.","journal-title":"JAMA."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06730-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-06730-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06730-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T20:10:50Z","timestamp":1616443850000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-06730-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6730"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06730-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18712\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18712\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18712\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"2 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments and the ethical standards of the institutional research ethics committee of the Medical Council of the federal state of Rhineland-Palatine. The study was approved by the research ethics committee of the Medical Council of the state of Rhineland-Palatine on 24 March 2017 (REC No. 837.109.17(10943). Written informed consent to participate was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable - only de-identified data was used in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}